We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Novartis’ cancer drug Gleevec and other drugs in its class can put patients at risk of heart failure, according to a study published in the July 23 issue of Nature Medicine.
Analysts are projecting a sunny outlook for Abbott Laboratories based on 2006 second-quarter results — despite some company challenges.
At first glance, the company may seem to be faring worse than it actually is, said stock market website www.SeekingAlpha.com Editor Jonathan Liss.
Some doctors are buying fewer medical devices because of planned cuts to Medicare reimbursements for certain medical imaging services. The cuts are slated to start in January 2007.
TheJournal of the American Medical Association (JAMA) July 19 published a correction — the second this month — in which they said the authors of an article did not disclose ties to the drug industry when they submitted their article manuscript.
As many as 18,000 medical devices are in danger of being pulled off the Australian marketplace if manufacturers don’t get their products assessed against provisions of a new system established by the Therapeutic Goods (Medical Devices) Regulations of 2002 and entered into the Australian Register of Therapeutic Goods by Oct. 4, 2007.
Peru’s Ministry of Health has issued proposed rules covering the manufacture, production, control, postmarket surveillance, import and export of medical devices, diagnostic agents and other healthcare products.
An initial round of trade negotiations between the U.S. and South Korea in early June has “significant implications” for the device and diagnostics industry, AdvaMed said June 27.
Nearly 200 medical device manufacturers, importers and distributors have registered with Malaysia’s web-based system of Voluntary Registration for Medical Device Establishments (MeDVER) since the program took effect in January.